The Anti-EBV (EBNA-1) IgG test is performed to determine whether a person has been previously infected with Epstein-Barr Virus (EBV). It is used to diagnose infectious mononucleosis, monitor the progression of EBV-related cancers, and to assess the immune status of transplant recipients.